Bronchiectasis medical therapy

Jump to navigation Jump to search

Bronchiectasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bronchiectasis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bronchiectasis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bronchiectasis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bronchiectasis medical therapy

CDC on Bronchiectasis medical therapy

Bronchiectasis medical therapy in the news

Blogs on Bronchiectasis medical therapy

Directions to Hospitals Treating Bronchiectasis

Risk calculators and risk factors for Bronchiectasis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.

Overview

Along with treatment of bronchiectasis, it is important to treat the underlying condition if one is present. The medical therapy is divided into medical treatment and physiologic strategies. The medical treatment consists of patient education, treatment of the acute exacerbations, prophylactic treatment, vaccination and other therapies. The physiotherapy strategies focuses on airway clearance and pulmonary rehabilitation.

Bronchiectasis Medical Therapy

Medical Treatment

Patient Education

  • The patients should understand their diagnosis clearly
  • Smoking cessation, regular exercise, and proper nutrition should be advised
  • The patient should know how to self-manage acute exacerbations with a home supply of antibiotics

Treatment of Acute Exacerbations

  • Exacerbations can be defined as patients reporting four or more of the following symptoms:
  • Change in sputum production
  • Dyspnea
  • Cough
  • Fever > 38°C
  • wWheeze
  • Decreased exercise tolerance
  • Fatigue
  • Reduced pulmonary function
  • Changes in chest sounds
  • Radiographic changes consistent with a new infection
  • The mainstay of treatment is antibiotic therapy
  • Once the sputum specimen is collected and sent for culture, a targeted antibiotic therapy is recommended.
  • It is considered chronic if the same microorganism is detected in three or more consecutive cultures separated by at least 1 month over a period of 6 months.[1]
  • Intravenous (IV) antibiotics may be needed if there has been: no response to oral antibiotics, systemic deterioration, or if the organism is sensitive only to IV agents[1]
  • Allergic bronchopulmonary aspergillosis (ABPA)
  • Oral prednisone 0.5 to 1 mg/kg per day for two weeks followed by alternate day therapy tapered over three to six months
  • A 16 week course of an antifungal agent, such as itraconazole or voriconazole, may be added in patients who require large doses of glucocorticoids
Culture Growth Antibiotics Dosage
Haemophilus influenzae type B Amoxicillin 1 g three times daily for two weeks
Haemophilus influenzae type B Doxycycline 100 mg twice daily for two weeks
Haemophilus influenzae type B (β-lactamase-positive strain) Augmentin 625 mg three times daily for two weeks
Pseudomonas aeruginosa Ciprofloxacin 500-750 mg twice daily for two weeks
If resistant to Pseudomonas aeruginosa Ceftazidime 2 g three times daily for two weeks (IV)
If resistant to Pseudomonas aeruginosa Tazocin 4.5 g three times daily IV
If resistant to Pseudomonas aeruginosa Meropenem 1 g three times daily IV
Streptococcus pneumoniae Amoxicillin 1 g threes times daily for two weeks
Moraxella catarrhalis Augmentin 625 mg three times daily for two weeks
Moraxella catarrhalis Ciprofloxacin 500 mg twice daily for two weeks
Staphylococcus aureus Flucloxacillin 1 g once a day for two weeks

Prophylactic Treatment

  • National guidelines recommend that patients suffering from three or more exacerbations per year, should be considered for long-term antibiotics.[1]
  • Macrolide daily or three times weekly
  • Amoxicillin 500 mg twice daily or doxycycline 100 mg twice daily for patients who are not candidates for long-term macrolide administration

Vaccination

  • There has been some evidence to support that the yearly influenza vaccine reduces morbidity, mortality, and healthcare costs with high-risk patients

Other Therapies

Physiotherapy Strategies

Airway Clearance

  • Postural Drainage
  • Autogenic Drainage
  • Active Cycle of Breathing Techniques
  • Positive Expiratory Pressure (PEP)
  • Oscillatory PEP devices
  • High-frequency chest wall percussion

Pulmonary Rehabilitation

  • Exercise training
  • Nutritional counseling
  • Educationof the patient's disease and how to manage it
  • Techniques on how to conserve energy
  • Strategies on breathing
  • Psychological counseling

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 McDonnell MJ, Ward C, Lordan JL, Rutherford RM (2013). "Non-cystic fibrosis bronchiectasis". QJM. 106 (8): 709–15. doi:10.1093/qjmed/hct109. PMID 23728208.

Template:WH Template:WS